Clinical Laserthermia Systems (CLS) (publ), participates at the European Conference on Interventional Oncology ECIO in Amsterdam, the Netherlands, April 8-11. CLS is Gold Sponsor this year, which means increasing our visibility during the event, among other things by organizing one hour's symposium focusing on imILT®, the method in an immunological context and presenting the studies we carry out on pancreatic cancer indication. The symposium is held in collaboration with Dr Belarmino Gonçalves, Professor Olivier Turrini, Professor Gunnar Hedlund and, the co-founder, Professor Karl-Göran Tranberg, who will all talk about different aspects of imILT. The symposium will take place on Tuesday April 9thand is chaired by Professor Andreas Mahnken.
On Wednesday, April 10th, CLS will participate in a hands-on workshop for "Tumor ablation". The purpose of ECIO's hands-on workshops is that different industrial players, in an educational format, get the opportunity to show their technology and share knowledge and experience in various medical indications.
At ECIO, CLS also, in addition to the symposium and workshop, has a booth where we demonstrate the TRANBERG® | Thermal Therapy System, including our non-cooled fiber and instruments. We also show the concept of the navigation platform for MR temperature monitoring, that we are currently developing within the framework of our partnerships with Image Guided Therapy SA (IGT) and Siemens Healthineers.
ECIO was held for the first time in 2008 and since 2012 it is an annual conference, aimed for experts in interventional oncology, i.e. interventional radiology focusing on future for cancer treatment. These treatments are typically less invasive than traditional surgery and are performed by image guidance such as computer tomography (CT) or magnetic resonance imaging (MRI) or ultrasound (US). CLS is a member of the CIRSE (Cardiovascular and Interventional Radiological Society of Europe) organization behind the conference. Last year's ECIO in Vienna had more than 1,400 participants, which is a record for the event.
More information is available on ECIO at www.ecio.org
This press release has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version.
Lars-Erik Eriksson, CEO, Clinical Laserthermia Systems AB (publ)
Tel: +46 - (0)702 - 90 33 00 E-mail: firstname.lastname@example.org
Clinical Laserthermia Systems AB (publ),develops and sells the TRANBERG®|Thermal Therapy System and specially designed sterile disposable products for safe, gentle and effective treatment of cancerous tumors. The products are marketed for image-guided laser ablation and for treatment with immuno-stimulating interstitial laser thermotherapy, imILT®. The company, which is headquartered in Lund Sweden and has a subsidiary in Berlin, Germany and Boston, MA, USA, is listed Nasdaq First North under the ticker CLS B. Certified Adviser:Västra Hamnen Corporate Finance AB, Tel: +46 40 200 250, E-mail: email@example.com. Further information is available on www.clinicallaser.se
(c) 2019 Cision. All rights reserved., source Press Releases - English